Institute of Medicine

Institute of Medicine
Name	Institute of Medicine
Formation	1970
Dissolution	2015
Successor	National Academy of Medicine
Type	nonprofit, honorific, advisory body
Headquarters	Washington, D.C.
Location	United States
Leader title	President
Leader name	Victor Dzau
Parent organization	National Academy of Sciences

Contents

Institute of Medicine The Institute of Medicine was an American nonprofit, nongovernmental advisory body established to provide objective, evidence-based guidance on health and biomedical policy. It convened experts from across Harvard University, Johns Hopkins University, University of California, San Francisco, Mayo Clinic, and Centers for Disease Control and Prevention to address health challenges for the United States and internationally. Through committee reports and consensus studies, it influenced deliberations in venues such as the United States Congress, World Health Organization, Department of Health and Human Services, Veterans Health Administration, and National Institutes of Health.

History

The Institute of Medicine was created in 1970 by an act of the United States Congress under the charter of the National Academy of Sciences to advise on health policy, clinical practice, and public health. Early work drew on leaders affiliated with National Institutes of Health, American Medical Association, American Public Health Association, Kaiser Permanente, and Fred Hutchinson Cancer Research Center to respond to issues raised by the 1969 influenza pandemic and advances from Wilhelm Röntgen–era technologies. During the 1970s and 1980s the Institute issued influential reports that intersected with initiatives at Food and Drug Administration, Centers for Medicare & Medicaid Services, World Bank, and Pan American Health Organization. In the 1990s and 2000s its panels included scholars from Columbia University, Stanford University, University of Pennsylvania, Yale University, and University of Chicago who produced guidance during emerging crises such as the 2001 anthrax attacks and the HIV/AIDS pandemic. The Institute operated until a reconstitution in 2015 when it was rebranded under the auspices of the National Academy of Sciences as the National Academy of Medicine.

Governance combined elected membership and appointed trustees drawn from entities such as American Academy of Pediatrics, Association of American Medical Colleges, Royal Society (as an international comparator), Bill & Melinda Gates Foundation (as donor partner), and university medical centers like Cleveland Clinic. Its membership included Nobel laureates affiliated with Rockefeller University, directors from Salk Institute, and senior clinicians from Brigham and Women's Hospital. Administrative oversight was coordinated with the National Research Council, and oversight relationships linked to committees liaising with the United States Congress and executive branch agencies including Office of Management and Budget. Presidents such as Victor Dzau led strategic planning, while boards incorporated ethicists from Johns Hopkins Berman Institute of Bioethics and legal scholars associated with Georgetown University.

The Institute convened consensus studies, systematic reviews, and workshops that informed policy at World Health Organization, Global Fund to Fight AIDS, Tuberculosis and Malaria, and United Nations Children's Fund. It issued clinical guidelines and practice standards that were adopted by hospitals like Massachusetts General Hospital, health systems such as Intermountain Healthcare, and professional societies including American College of Physicians and American Academy of Family Physicians. The body conducted capacity-building activities for ministries of health in countries such as India, Kenya, and Brazil, collaborating with Pan American Health Organization and Centers for Disease Control and Prevention. It maintained task forces on patient safety responding to findings from facilities including Johns Hopkins Hospital and Mount Sinai Hospital.

Major publications included reports that reshaped practice and policy: studies on patient safety that influenced Agency for Healthcare Research and Quality initiatives; reports on medical errors that prompted reforms across Veterans Health Administration; analyses of workforce shortages that were cited by Health Resources and Services Administration; and guidance on obesity referenced by Centers for Disease Control and Prevention and World Health Organization. The Institute's reports on vaccine safety and immunization schedules were used by Advisory Committee on Immunization Practices and pediatricians at Children's Hospital of Philadelphia. Work on bioethics and research integrity resonated with regulations promulgated by Office for Human Research Protections and university institutional review boards at University of Michigan and University of California, Los Angeles.

Funding derived from a mix of federal contracts and grants from agencies such as National Institutes of Health, private foundations including Robert Wood Johnson Foundation and Carnegie Corporation, corporate sponsors from the pharmaceutical and device industries such as Pfizer and Johnson & Johnson, and donations from health systems like Kaiser Permanente. To manage perceived conflicts, the Institute adopted disclosure policies and conflict-of-interest rules comparable to those used by National Academies Press and scholarly journals like New England Journal of Medicine; nevertheless, debates persisted involving stakeholders such as Pharmaceutical Research and Manufacturers of America and advocacy groups like American Heart Association about panel composition and funding transparency. Oversight mechanisms included recusals and public disclosure lists that paralleled standards at World Health Organization expert panels.

The Institute's legacy includes enduring influence on patient safety, population health metrics, and translational research policy adopted by National Institutes of Health, Centers for Medicare & Medicaid Services, and international bodies like World Health Organization. In 2015 the Institute was reconstituted as the National Academy of Medicine under the umbrella of the National Academies of Sciences, Engineering, and Medicine, aligning it more closely with sister bodies such as the National Academy of Engineering and the National Academy of Sciences. Its reports remain cited by courts, legislatures, and health agencies including Supreme Court of the United States proceedings, United States Congress hearings, and policy offices within White House Office initiatives, continuing an institutional role in shaping 21st-century health policy.

Category:Medical research organizations